Guillain–Barré syndrome following coronavirus disease vaccine: First report from Nepal
ChAdOx1 nCoV-19 is an effective and well-tolerated coronavirus disease 2019 vaccine. However, rare cases of serious adverse events have been reported with it. We report a patient who did not have active or prior coronavirus disease 2019 infection, who developed Guillain–Barré syndrome 7 days followi...
Full description
Bibliographic Details
| Main Authors: |
Prajjwol Luitel,
Bibek Poudel,
Devansh Upadhyay,
Sujan Paudel,
Nishan Tiwari,
Bikram Prasad Gajurel,
Ragesh Karn,
Reema Rajbhandari,
Aashish Shrestha,
Niraj Gautam,
Rajeev Ojha |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
SAGE Publishing
2022-05-01
|
|---|
| Series: | SAGE Open Medical Case Reports
|
|---|
| Online Access: | https://doi.org/10.1177/2050313X221100876
|
|---|